February 2, 2012
The European Medicines Agency is preparing for the introduction of the new pharmacovigilance legislation in July this year, which will bring the biggest change to the legal framework since the establishment of the Agency in 1995.

January 23, 2012
The European Medicines Agency has released a concept paper on the development of a guideline on the evaluation of pharmacogenomic methodologies in the evaluation of authorised medicines for public consultation.

January 20, 2012
Meeting highlights are available from the January 16-19, 2012 meeting of the Committee for Medicinal Products for Human Use (CHMP).

January 20, 2012
The European Medicines Agency has released a guideline on how pharmaceutical companies should test biosimilar medicines containing interferon beta for public consultation.

January 20, 2012
The European Medicines Agency has recommended the suspension of all marketing authorisations for meprobamate-containing medicines for oral use in the European Union, because their risks are greater than their benefits.

January 16, 2012
Meeting highlights are available from the January 2012 meeting of the Committee for Orphan Medicinal Products.